Successful Cases
In October 2017, Shanghai Shengdi Medical Project was successfully signed.
Release time:
2017-11-28 02:09
Shanghai Shengdi Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Jiangsu Hengrui Pharmaceutical Co., Ltd. The company is located in Zhangjiang High-tech Park, Pudong, Shanghai, with a registration cost of 0.25 billion yuan and an area of 41000 square meters. It has core departments such as Hengrui new drug research and development, clinical research, patent registration, medical affairs and product market management. The company will adhere to the strategy of innovation and international development, and strive to become an innovative R & D center of Hengrui Medicine.
The final procurement AS-Slimlan950 flap-type quick access doors, a total of 5 channels, and 3 groups of VIP-SL930 logistics doors to provide safe personnel access protection for office buildings.
